LRMR
Larimar Therapeutics Inc
3.30$
-14.1%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | – | 0.00 | – | – | – | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | – | 0.00 | – | – | – | |
| 0.15 | 0.24 | 0.24 | 0.31 | 0.22 | 0.42 | 0.42 | 0.36 | 0.57 | 0.70 | 0.29 | 0.27 | 1.51 | |
| 0.09 | 0.08 | 0.07 | 0.08 | 0.07 | 0.07 | 0.07 | 0.07 | 0.06 | 0.05 | 0.07 | 0.06 | 0.21 | |
| 0.24 | 0.32 | 0.31 | 0.39 | 0.29 | 0.49 | 0.49 | 0.43 | 0.63 | 0.75 | 0.37 | 0.33 | 1.72 | |
| -0.24 | -0.32 | -0.31 | -0.39 | -0.29 | -0.49 | -0.49 | -0.43 | -0.63 | -0.75 | -0.37 | -0.33 | -1.72 | |
| -0.21 | -0.30 | -0.27 | -0.34 | -0.24 | -0.45 | -0.46 | -0.41 | -0.61 | -0.73 | -0.35 | -0.32 | -1.66 | |
| 0.00 | 0.00 | 0.00 | – | 0.00 | – | – | – | – | – | – | – | – | |
| -0.21 | -0.30 | -0.27 | -0.34 | -0.24 | -0.45 | -0.46 | -0.41 | -0.61 | -0.73 | -0.35 | -0.32 | -1.66 | |
| -0.20 | -0.29 | -0.27 | -0.34 | -0.24 | -0.45 | -0.46 | -0.41 | -0.61 | -0.73 | -0.35 | -0.31 | -1.66 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.